Aizer, Ayal A <br/><br/>
Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.  [electronic resource] 

 -  Journal of the National Comprehensive Cancer Network : JNCCN  Jan 2015 
 - 61-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-1413 
<br/><br/><label>Standard No.: </label>10.6004/jnccn.2015.0009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Combined Modality Therapy--adverse effects<br/>Cost of Illness<br/>Humans<br/>Incidence<br/>Male<br/>Morbidity<br/>Neoplasm Staging<br/>Prostatic Neoplasms--complications<br/>Risk Factors<br/>SEER Program<br/>United States--epidemiology